Cover Image

無線支援的注射設備 2022年

Wirelessly Enabled Injection Devices to 2022

出版商 Greystone Research Associates 商品編碼 428084
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
無線支援的注射設備 2022年 Wirelessly Enabled Injection Devices to 2022
出版日期: 2017年01月30日 內容資訊: 英文

本報告提供加入無線連接技術的藥物注射設備的市場相關調查,其結構與提供給患者、HCP (醫護人員) 的新功能,支援無線的注射器帶給患者的優點,無線支援設備現在聚焦的治療領域,支撐無線支援注射設備成長的企業,及無線支援注射設備市場成長的主要促進要素等相關詳細分析。



  • 可注射設備的技術
  • 市場成長的促進要素
    • 自我施打的增加
    • 居家醫療的增加
    • 不遵從服藥的成本
    • 生物學的注射劑、患者安全性
  • 新興經濟各國的影響


  • 無線技術
  • Bluetooth
  • 行動電話
  • NFC
  • RFID


  • 穿戴式設備
  • 終端型設備
  • 設備的區分
    • 非特定藥物用連網型注射器
    • 自動連網型注射器
    • 供應商專用連接性的平台
    • 第三方的連接性設備


  • 過敏性反應
  • 自體免疫疾病
  • 心血管
  • 糖尿病
  • 荷爾蒙補充


  • 法規問題
  • HIPAA及患者隱私
  • 資料安全
  • 網路安全及患者安全性
  • 患者安全性
  • 用戶訓練


Product Code: WEJ874F17

Connecting Patients and Caregivers

For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life. Wirelessly enabled devices - drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants. Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.

What You Will Learn

  • What drug injection devices incorporate wireless connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?
  • What benefits do wirelessly enabled drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication?
  • What therapeutic areas are the current focus of wirelessly enabled devices?
  • Who are the companies behind the growth of wirelessly enabled injection devices? What are their development activities and corporate alliances and affiliations
  • What is the importance of pharma-device alliances and design partnerships on wirelessly enabled drug injection device commercialization and market access?
  • What does the current market for wirelessly enabled drug injection devices look like? What will it look like in 2022?
  • What are the key market drivers for the growth of wirelessly enabled injection devices?

Market-driven Product Strategies

A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.

‘Much of the activity surrounding connected drug injection devices is focused on chronic diseases - conditions where the ability of caregivers to access data on patient self-administration activities, patient reported outcomes, and feedback on the user experience can yield significant benefits in patient Quality of Life.'

Table of Contents

Executive Summary

Wireless Injection Devices - The Opportunity

  • Injectable Device Technology
  • Market Drivers
    • The Growth of Self-Administration
    • The Rise in Home Healthcare
    • The Cost of Non-Adherence
    • Biological Injectables and Patient Safety
  • The Impact of Developing Economies

Connectivity Technologies

  • Wireless Technologies
  • Bluetooth
  • Cellular
  • Near Field Communications
  • RFID

Wirelessly Enabled Device Classes

  • Wearable Devices
  • Handheld Devices
  • Device Segments
    • Non-drug Specific Connected Injectors
    • Automated Connected Injectors
    • Vendor-specific Connectivity Platforms
    • Third Party Connectivity Devices

Near-term Markets for Connected Injection Devices

  • Anaphylaxis
  • Autoimmune Disease
  • Cardiovascular
  • Diabetes
  • Hormone Replacement

Market Factors

  • Regulatory Issues
  • HIPAA and Patient Privacy
  • Data Security
  • Cybersecurity and Patient Safety
  • Patient Safety
  • User Training

Company Profiles

Back to Top